Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Metastatic Colorectal Adenocarcinoma
Clinical trial NCT01639131 · TERMINATED
Trial details
- NCT number
- NCT01639131
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-10
- Primary completion
- 2016-10-03
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.